UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

First German-language, multinational master's degree in medical insurance

Versicherungsmedizin, 2011-03, Vol.63 (1), p.1-2

2011

Volltextzugriff (PDF)

Health-related quality of life of people with severe traumatic injury: a longitudinal study using the SF-36 health survey

Versicherungsmedizin, 2013-06, Vol.65 (2), p.86-90

2013

Volltextzugriff (PDF)

GM-CSF in the treatment of skin ulceration in breast cancer

Journal of wound care, 1997-04, Vol.6 (4), p.165-166

Wandl, U B

1997

Volltextzugriff (PDF)

Impact of interferon alpha‐induced cytogenetic improvement on survival in chronic myelogenous leukaemia

British journal of haematology, 1993-03, Vol.83 (3), p.399-403

1993

Volltextzugriff (PDF)

Liver failure due to recombinant alpha interferon for chronic myelogenous leukaemia

The Lancet (British edition), 1992-01, Vol.339 (8785), p.123-124

1992

Volltextzugriff (PDF)

Combination therapy with interferon alpha‐2b plus low‐dose interferon gamma in pretreated patients with Ph‐positive chronic myelogenous leukaemia

British journal of haematology, 1992-08, Vol.81 (4), p.516-519

1992

Volltextzugriff (PDF)

No correlation between site of breakpoint in the BCR gene and platelet counts in philadelphia chromosome-positive CML

Leukemia research, 1992-09, Vol.16 (9), p.937-939

1992

Volltextzugriff (PDF)

No correlation between the type of bcr-abl hybrid messenger RNA and platelet counts in chronic myelogenous leukemia

Blood, 1992-10, Vol.80 (7), p.1854-1855

1992

Volltextzugriff (PDF)

New findings on the influence of body weight on mortality

Versicherungsmedizin, 2005-12, Vol.57 (4), p.167-170

2005

Volltextzugriff (PDF)

Bcr-abl-positive and -negative clonogenic cells in CML patients undergoing long-term interferon treatment

Leukemia, 1994-05, Vol.8 (5), p.776-779

1994

Volltextzugriff (PDF)

TREATMENT OF ESSENTIAL THROMBOCYTHAEMIA WITH INTERFERON ALPHA-2b

The Lancet (British edition), 1989-01, Vol.333 (8629), p.96-96

1989

Volltextzugriff (PDF)

Treatment of chronic myelogenous leukemia with different cytokines

Seminars in oncology, 1992-04, Vol.19 (2), p.88-94

1992

Volltextzugriff (PDF)

Back to work--how can this be achieved?

Therapeutische Umschau, 2007-08, Vol.64 (8), p.451

2007

Volltextzugriff (PDF)

Health risks of smoking--up to now, clearly underestimated

Versicherungsmedizin, 2004-06, Vol.56 (2), p.72

2004

Volltextzugriff (PDF)

DNA-flow cytometry studies in blood and marrow cells from chronic myelogenous leukemia patients treated with interferon alpha-2b

Leukemia research, 1990, Vol.14 (10), p.905-908

1990

Volltextzugriff (PDF)

Treatment of high-risk, nonseminomatous testicular cancer with cisplatin, ifosfamide and bleomycin : long-term results

Annals of oncology, 1992-02, Vol.3 (2), p.123-126

1992

Volltextzugriff (PDF)

Interferon alpha and gamma alter the binding of progenitor cells to fibronectin of patients with CML

Leukemia, 1993-08, Vol.7 (8), p.1300-1301

1993

Volltextzugriff (PDF)

Extent to which a claimant's loss-mitigation and cooperation obligations towards the insurer are enforceable--requirements for an expert medical opinion

Versicherungsmedizin, 2007-03, Vol.59 (1), p.26-28

2007

Volltextzugriff (PDF)

Treatment of Metastatic Carcinoid Tumors and the Carcinoid Syndrome with Recombinant interferon Alpha

Acta oncologica, 1991, Vol.30 (5), p.603-605

1991

Volltextzugriff (PDF)

Phase II study of high-dose medroxyprogesterone acetate in advanced malignant melanoma

British journal of cancer, 1989-06, Vol.59 (6), p.948-948

1989

Volltextzugriff (PDF)

Original article: Treatment of high-risk, nonseminomatous testicular cancer with cisplatin, ifosfamide and bleomycin: Long-term results

Annals of oncology, 1992-02, Vol.3 (2), p.123-126

1992

Volltextzugriff (PDF)

Clonogenic assay is not predictive but reflects therapeutic efficacy of interferons in the treatment of chronic myelogenous leukemia

International journal of cell cloning, 1992, Vol.10 (5), p.292-298

1992

Volltextzugriff (PDF)

Clonogenic Hemopoietic Precursors in Bone Marrow Transplantation

Blood, 1987-11, Vol.70 (5), p.1425-1432

1987

Volltextzugriff (PDF)

A prospective randomized comparison of single-agent interferon (IFN)-alpha with the combination of IFN-alpha and low-dose IFN-gamma in chronic myelogenous leukaemia

European journal of haematology, 1992-02, Vol.48 (2), p.93-98

1992

Volltextzugriff (PDF)

Tumor necrosis factor α modifies resistance to interferon α in vivo : first clinical data

Cancer Immunology Immunotherapy, 1992-09, Vol.35 (5), p.342-346

1992

Volltextzugriff (PDF)

1 – 25 von 71

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(44)

Publikationsform

Sprache

Englisch
(57)
Deutsch
(15)

Erscheinungsjahr

n.n

Thema

Humans
(48)
Biological And Medical Sciences
(25)
Female
(23)
Male
(23)
Adult
(22)
Life Sciences & Biomedicine
(22)
Medical Sciences
(22)
Middle Aged
(22)
Science & Technology
(22)
Pharmacology. Drug Treatments
(18)
Antineoplastic Agents
(15)
Recombinant Proteins
(15)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Therapy
(13)
Immunotherapy
(12)
Interferon-Alpha - Therapeutic Use
(12)
Aged
(11)
Oncology
(11)
Adolescent
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(10)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Genetics
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

First German-language, multinational master's degree in medical insurance

Health-related quality of life of people with severe traumatic injury: a longitudinal study using the SF-36 health survey

GM-CSF in the treatment of skin ulceration in breast cancer

Impact of interferon alpha‐induced cytogenetic improvement on survival in chronic myelogenous leukaemia

Liver failure due to recombinant alpha interferon for chronic myelogenous leukaemia

Combination therapy with interferon alpha‐2b plus low‐dose interferon gamma in pretreated patients with Ph‐positive chronic myelogenous leukaemia

No correlation between site of breakpoint in the BCR gene and platelet counts in philadelphia chromosome-positive CML

No correlation between the type of bcr-abl hybrid messenger RNA and platelet counts in chronic myelogenous leukemia

New findings on the influence of body weight on mortality

Bcr-abl-positive and -negative clonogenic cells in CML patients undergoing long-term interferon treatment

TREATMENT OF ESSENTIAL THROMBOCYTHAEMIA WITH INTERFERON ALPHA-2b

Treatment of chronic myelogenous leukemia with different cytokines

Back to work--how can this be achieved?

Health risks of smoking--up to now, clearly underestimated

DNA-flow cytometry studies in blood and marrow cells from chronic myelogenous leukemia patients treated with interferon alpha-2b

Treatment of high-risk, nonseminomatous testicular cancer with cisplatin, ifosfamide and bleomycin : long-term results

Interferon alpha and gamma alter the binding of progenitor cells to fibronectin of patients with CML

Extent to which a claimant's loss-mitigation and cooperation obligations towards the insurer are enforceable--requirements for an expert medical opinion

Treatment of Metastatic Carcinoid Tumors and the Carcinoid Syndrome with Recombinant interferon Alpha

Phase II study of high-dose medroxyprogesterone acetate in advanced malignant melanoma

Original article: Treatment of high-risk, nonseminomatous testicular cancer with cisplatin, ifosfamide and bleomycin: Long-term results

Clonogenic assay is not predictive but reflects therapeutic efficacy of interferons in the treatment of chronic myelogenous leukemia

Clonogenic Hemopoietic Precursors in Bone Marrow Transplantation

A prospective randomized comparison of single-agent interferon (IFN)-alpha with the combination of IFN-alpha and low-dose IFN-gamma in chronic myelogenous leukaemia

Tumor necrosis factor α modifies resistance to interferon α in vivo : first clinical data

Suchergebnisse filtern